Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluated the efficacy and safety of ospemifene for vulvar and vaginal atrophy in postmenopausal women; results have been posted followin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar and Vaginal Atrophy

Drugs mentioned

• Osphena (ospemifene)

Snippet

Sponsor: Shionogi | Conditions: Atrophy, Vaginal Diseases | Phase 2 | Status: COMPLETED | Results posted: 2013-06-28